glp-1 addiction trials medications get at the heart of addiction: study – WashU Medicine Glucagon-like peptide-1 receptor agonists and
Description
doi: 10.3389/fendo.2021.669448
Nat Med 18 , 666667 (2012)
Ozempic use has also been linked to hundreds of deaths
Geographic Availability Available in all 50 states (eligibility for compounded meds varies by state) Clinical Oversight and Safety Licensed providers review each case and personalize the dose
Some start with semaglutide given its lower price and excellent results, then switch to tirzepatide if they plateau or want to maximize outcomes
